Stefano Molica
Adherence to ibrutinib remains an unmet clinical need in chronic lymphocytic leukemia
Molica, Stefano; Allsup, David John; Polliack, Aaron
Authors
Dr David Allsup D.J.Allsup@hull.ac.uk
Senior Lecturer in Haematology and Honorary Consultant
Aaron Polliack
Citation
Molica, S., Allsup, D. J., & Polliack, A. (2022). Adherence to ibrutinib remains an unmet clinical need in chronic lymphocytic leukemia. Leukemia & Lymphoma, https://doi.org/10.1080/10428194.2022.2087072
| Journal Article Type | Commentary |
|---|---|
| Acceptance Date | May 30, 2022 |
| Online Publication Date | Jun 15, 2022 |
| Publication Date | 2022 |
| Deposit Date | Jun 27, 2022 |
| Publicly Available Date | Jun 16, 2023 |
| Journal | Leukemia and Lymphoma |
| Print ISSN | 1042-8194 |
| Electronic ISSN | 1029-2403 |
| Publisher | Taylor and Francis |
| Peer Reviewed | Peer Reviewed |
| DOI | https://doi.org/10.1080/10428194.2022.2087072 |
| Public URL | https://hull-repository.worktribe.com/output/4020606 |
Files
This file is under embargo until Jun 16, 2023 due to copyright reasons.
Contact D.J.Allsup@hull.ac.uk to request a copy for personal use.
You might also like
Time-limited, chemotherapy-free treatment comes of age in chronic lymphocytic leukaemia
(2022)
Journal Article